Human Rhinovirus Species Associated With Hospitalizations for Acute Respiratory Illness in Young US Children
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. The Journal of Infectious Diseases
(Impact Factor: 6).
12/2011; 204(11):1702-10. DOI: 10.1093/infdis/jir634
The contribution of human rhinovirus (HRV) to severe acute respiratory illness (ARI) is unclear.
To assess the association between HRV species detection and ARI hospitalizations.
Children <5 years old hospitalized for ARI were prospectively enrolled between December 2003 and April 2005 in 3 US counties. Asymptomatic controls were enrolled between December 2003 and March 2004 and between October 2004 and April 2005 in clinics. Nasal and throat swab samples were tested for HRV and other viruses (ie, respiratory syncytial virus, human metapneumovirus, parainfluenza virus, and influenza virus) by reverse-transcription-polymerase chain reaction, and genetic sequencing identified HRV species and types. HRV species detection was compared between controls and patients hospitalized during months in which controls were enrolled.
A total of 1867 children with 1947 ARI hospitalizations and 784 controls with 790 clinic visits were enrolled and tested for HRV. The HRV-A detection rate among participants ≥24 months old was 8.1% in the hospitalized group and 2.2% in the control group (P = .009), and the HRV-C detection rates among those ≥6 months old were 8.2% and 3.9%, respectively (P = .002); among younger children, the detection rates for both species were similar between groups. The HRV-B detection rate was ≤1%. A broad diversity of HRV types was observed in both groups. Clinical presentations were similar among HRV species. Compared with children infected with other viruses, children with HRV detected were similar for severe hospital outcomes and more commonly had histories or diagnoses of asthma or wheezing.
HRV-A and HRV-C were associated with ARI hospitalization and serious illness outcomes.
Available from: Vivian Luchsinger
- "Similar results were found by Marguet et al. . It is known that severe RSV infections mainly affect very young infants  , while severe HRV infections principally could affect children older than 6 months of age, or infants with previous morbidity   . Certain clinical conditions increase the risk of developing severe RSV disease. "
[Show abstract] [Hide abstract]
Respiratory syncytial virus (RSV) and rhinovirus (HRV) are the main cause of acute lower respiratory tract infections (ALRTIs) in infants. Viral and host-related risk factors for severe disease have also not been clearly established.
to assess whether certain viral features of RSV and, or HRV are associated with severe ALRTI. Study design: RSV and HRV were studied in nasopharyngeal samples of infants by immunofluorescence, Luminex® and/or real-time RT-PCR assays. Quantitation and genotyping of RSV and HRV by PCR were done.
Of 124 virus positive specimens, 74 (59.7%) had RSV; 22 (17.7%) HRV and 28 (22.6%) RSV-HRV co-infection. Hospitalization was required in 57/74 RSV infants (77.0%); in 10/22 HRV cases (45.5%) (p= 0.006) and in 15/28 co-infected by both viruses (53.6%) (p= 0.003). Severe cases were 33/74 (44.6%) RSV infections, 2/22 HRV cases (9.1%), (p < 0.002) and 6/28 (21.4%) patients co-infected by RSV-HRV (p <0.026). Three genotypes (NA1, B7, B9) of RSV circulated during the study. In 33 severe infants, NA1 was detected in 19 cases (57.6%); B7 in 13 (39.4%) and B9 in 1 (3.0%) (p < 0.01; OR = 10.0). RSV loads were similar between outpatients and hospitalized infants (p = 0.7) and among different severities (p = 0.7). NA1 loads were higher than other strains (p = 0.049). Three geno-groups of HRV circulated homogeneously.
in very young infants, RSV cause more severe disease than HRV. Co-infection does not increase the severity of illness. NA1 RSV genotype was associated with major frequency of hospitalization, severe respiratory disease and higher viral load.
Journal of Clinical Virology 09/2014; 61(1). DOI:10.1016/j.jcv.2014.06.004 · 3.02 Impact Factor
Available from: Samuel Constant
- "Virology have also been documented (Broberg et al., 2011; Fuji et al., 2011; Tapparel et al., 2011). However, strong evidence is lacking to definitely claim that HRV-Cs might be more virulent or more adapted to the lower airway environment (Iwane et al., 2011; Lee et al., 2012; Tapparel et al., 2011). "
[Show abstract] [Hide abstract]
ABSTRACT: New molecular diagnostic tools have recently allowed the discovery of human rhinovirus species C (HRV-C) that may be overrepresented in children with lower respiratory tract complications. Unlike HRV-A and HRV-B, HRV-C cannot be propagated in conventional immortalized cell lines and their biological properties have been difficult to study. Recent studies have described the successful amplification of HRV-C15, HRV-C11, and HRV-C41 in sinus mucosal organ cultures and in fully differentiated human airway epithelial cells. Consistent with these studies, we report that a panel of clinical HRV-C specimens including HRV-C2, HRV-C7, HRV-C12, HRV-C15, and HRV-C29 types were all capable of mediating productive infection in reconstituted 3D human primary upper airway epithelial tissues and that the virions enter and exit preferentially through the apical surface. Similar to HRV-A and HRV-B, our data support the acid sensitivity of HRV-C. We observed also that the optimum temperature requirement during HRV-C growth may be type-dependent.
Virology 11/2013; 446(1-2):1-8. DOI:10.1016/j.virol.2013.06.031 · 3.32 Impact Factor
Available from: Felix Sanchez
- "Several studies have suggested differences in illness severity between HRV species, including a specific association of HRV-C with wheezing and asthma exacerbation [6,7,35]. In agreement with these studies, our results showed a higher frequency of dyspnea in subjects with HRV-C compared with other viruses; in addition, we noted an association of HRV-C detection with pre-existing respiratory diseases, in particular with asthma. "
[Show abstract] [Hide abstract]
ABSTRACT: Human rhinoviruses (HRVs) belong to the Picornaviridae family with high similarity to human enteroviruses (HEVs). Limited data is available from Latin America regarding the clinical presentation and strains of these viruses in respiratory disease.
We collected nasopharyngeal swabs at clinics located in eight Latin American countries from 3,375 subjects aged 25 years or younger who presented with influenza-like illness.
Our subjects had a median age of 3 years and a 1.2:1.0 male:female ratio. HRV was identified in 16% and HEV was identified in 3%. HRVs accounted for a higher frequency of isolates in those of younger age, in particular children < 1 years old. HRV-C accounted for 38% of all HRVs detected. Phylogenetic analysis revealed a high proportion of recombinant strains between HRV-A/HRV-C and between HEV-A/HEV-B. In addition, both EV-D68 and EV-A71 were identified.
In Latin America as in other regions, HRVs and HEVs account for a substantial proportion of respiratory viruses identified in young people with ILI, a finding that provides additional support for the development of pharmaceuticals and vaccines targeting these pathogens.
Virology Journal 10/2013; 10(1):305. DOI:10.1186/1743-422X-10-305 · 2.18 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.